Announcements Trials
Browse Landscape

Status

Unknown 3Recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 4Interventional 4

Sponsor

Cancer Type

Thoracic 4Gastrointestinal 3Tumor-Agnostic 2Other hematologic neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Small Cell Lung Carcinoma 1

Interventions

Blood Specimen Collection 53Surveys and Questionnaires 30Drug Therapy 27Immunotherapy 25Surgical Procedures, Operative 22Carboplatin 22Nivolumab 21Immune Checkpoint Inhibitors 20pembrolizumab 18osimertinib 18atezolizumab 17Observation 17Radiotherapy 16Bevacizumab 15Cisplatin 14Afatinib 14Specimen Handling 13Gene Expression Profiling 13Erlotinib Hydrochloride 13lorlatinib 12Pemetrexed 12Magnetic Resonance Spectroscopy 11Ipilimumab 11Immunohistochemistry 11Biopsy 11durvalumab 10alectinib 10Paclitaxel 10Bronchoscopy 10Tomography, X-Ray Computed 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Antineoplastic Agents × Thoracic × Clear all
NCT07166003 2025-09-10

NeoIP-Lung

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Recruiting
500 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05486988 2022-08-04

ctDNA as a Biomarker for Treatment in Advanced NSCLC

Fuzhou General Hospital

Unknown
500 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04663438 2020-12-11

Real World Study of Efficacy and Safety of Atezolizumab Plus Chemotherapy in Chinese Patients With ES-SCLC

Peking Union Medical College Hospital

Unknown
300 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT04115410 2020-05-28

PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study

Sungkyunkwan University

Unknown
4,724 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡